Yinzhe Xu
Overview
Explore the profile of Yinzhe Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang H, Zhang W, Cao J, Cao Y, Bi X, Zhao H, et al.
Biosci Trends
. 2024 Dec;
18(6):505-524.
PMID: 39721704
Up to half of hepatocellular carcinoma (HCC) cases are diagnosed at an advanced stage, for which effective treatment options are lacking, resulting in a poor prognosis. Over the past few...
2.
Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, et al.
Proc Natl Acad Sci U S A
. 2024 Feb;
121(8):e2314128121.
PMID: 38359291
Aberrant lysine lactylation (Kla) is associated with various diseases which are caused by excessive glycolysis metabolism. However, the regulatory molecules and downstream protein targets of Kla remain largely unclear. Here,...
3.
Xiao Y, Cao J, Zhang Z, Zeng C, Ou G, Shi J, et al.
Front Microbiol
. 2022 Apr;
13:830741.
PMID: 35464922
Background: The existence of hepatic cancer stem cells (CSCs) contributes to chemotherapy resistance and cancer recurrence after treatment or surgery. However, very little is known about the hepatitis B virus...
4.
Zhang W, Hu B, Han J, Wang Z, Ma G, Ye H, et al.
Front Oncol
. 2021 Nov;
11:747950.
PMID: 34737958
Background And Aims: Immunotherapy with PD-1 inhibitors combined with tyrosine kinase inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma (HCC). The aim of this study was...
5.
Pu Y, Song Y, Zhang M, Long C, Li J, Wang Y, et al.
Signal Transduct Target Ther
. 2021 Apr;
6(1):148.
PMID: 33850109
Intestinal epithelium serves as the first barrier against the infections and injuries that mediate colonic inflammation. Colorectal cancer is often accompanied with chronic inflammation. Differed from its well-known oncogenic role...
6.
Wang X, Teh C, Ishizawa T, Aoki T, Cavallucci D, Lee S, et al.
Ann Surg
. 2020 Dec;
274(1):97-106.
PMID: 33351457
Objective: To establish consensus recommendations for the use of fluorescence imaging with indocyanine green (ICG) in hepatobiliary surgery. Background: ICG fluorescence imaging has gained popularity in hepatobiliary surgery in recent...
7.
Xu Y, Chen M, Meng X, Lu P, Wang X, Zhang W, et al.
Surg Endosc
. 2020 Jun;
34(10):4683-4691.
PMID: 32500459
Background: Anatomical liver resection is an established procedure for primary hepatic tumors. Laparoscopic anatomical hepatectomy has been proven to be technically achievable from S1 to S8 in experienced hands. The...
8.
Meng X, Wang H, Xu Y, Chen M, Duan W, Lu S
Int J Surg Case Rep
. 2018 Dec;
53:406-409.
PMID: 30567056
Introduction: Total laparoscopic living donor right hepatectomy (TLDRH) is sporadically reported worldwide. Liver transection margin used to be determined by ischemic demarcation or intraoperative ultrasonography. To identify the site of...
9.
Tang H, Lu W, Li B, Li C, Xu Y, Dong J
Oncotarget
. 2017 Apr;
8(22):36857-36868.
PMID: 28415734
Background: Inflammation was considered to perform crucial roles in the development and metastasis of malignancies. A heightened neutrophil-lymphocyte ratio has been described to be associated with detrimental survivals in different...
10.
Xu Y, Chen J, Wang H, Zheng H, Feng D, Zhang A, et al.
Trials
. 2016 Oct;
17(1):492.
PMID: 27724929
Background: The high prevalence of hepatitis B virus (HBV) imposes a huge burden of hepatocellular carcinoma (HCC) in Asia. Surgical resection remains an important therapeutic strategy for HCC. Hepatic inflow...